Comprehensive analysis of biomarkers for prostate cancer based on ...

Biomarker Testing for Prostate Cancer Diagnosis (L37733) - CMS

ConfirmMDx is a tissue-based, multiplex epigenetic assay intended to improve risk-stratification of men being considered for repeat biopsy. The test uses ...

Amino Acid Profiles of Serum and Urine in Search for Prostate ...

There is a great interest in searching for diagnostic biomarkers in prostate cancer patients. The aim of the pilot study was to evaluate free amino acid ...

Biomarkers Archives - Grand Rounds in Urology

Their analysis was directed toward discovering a biomarker that can predict which men with intermediate-risk prostate cancer benefit from the addition of ADT to ...

Prostate Cancer - Uroweb - European Association of Urology

men with a PSA level of < 2 ng/mL at 60 years of age;. Postpone follow-up up to eight years in those not at risk. Weak. Stop early diagnosis of PCa based ...

A comprehensive analysis of ncRNA-mediated interactions reveals ...

A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma · Li Guo · Yihao Kang · Yiqi Xiong · Lin ...

Approaches to the discovery of non-invasive urinary biomarkers of ...

This study indicates that a tumor-specific urinary MMP fingerprint may noninvasively facilitate identification of cancer presence and type [47].

The Clinical Applications of Serum and Urinary Biomarkers in ...

based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003;44(1):8-15; discussion 15-6. doi: 10.1016/ s0302-2838(03) ...

Biomarkers Articles - UroToday

We have previously shown that urine- and plasma-based prostate-specific biomarkers when combined can predict high grade prostate cancer (PCa). Published ...

Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer

This study presents an analysis of immune biomarkers in biopsies from patients with metastatic prostate cancer. We describe tumor alterations ...

the next generation of biomarkers for liquid biopsy-based prostate ...

Prostate cancer (PCa) is a leading cause of cancer death for males in western countries. The current gold standard for PCa diagnosis - template needle ...

Circulating Tumor Cell Count and Overall Survival in mHSPC

Peripheral blood circulating tumor cell (CTC) count is the most extensively validated prognostic liquid biomarker in metastatic castration- ...

Prostate cancer markers: An update (Review)

Laxman et al (63) suggest using a multiplex biomarker analysis of urine involving proteins such as golgi phosphoprotein 2 and serine protease ...

Integration of expression datasets to identify biomarkers for accurate ...

The grading system for the classification of prostate cancer tumours involves a combination of factors: (1) PSA measurements, (2) Gleason score, ...

Prostate-Specific Antigen (PSA) Test - NCI

The single-parameter, structure-based IsoPSA assay demonstrates improved diagnostic accuracy for detection of any prostate cancer and high-grade ...

Diagnostic Biomarkers of Prostate Cancer in 2023 and Beyond

... cancer biomarkers and measures of clinical performance in the diagnosis of prostate cancer. Dr. Tosoian provides a thorough review of ...

Cancer biomarkers: Emerging trends and clinical implications for ...

When tailored to the field of oncology, a cancer biomarker specifically identifies characteristics of cancer, ideally with a high degree of ...

A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine ...

The diagnosis of the patients (PCa, BPH and prostatitis) was based on pathological analysis of the biopsy or prostatectomy specimens. The characteristics of the ...

Current Update on Biomarkers for Detection of Cancer - OUCI

... and multiplexing capabilities for simultaneous detection of cancer biomarkers (CB's). This study provides a comprehensive analysis of the most recent desig…

Identification of biomarkers for immunotherapy response in prostate ...

Methods: The transcriptome profiles of patients with prostate cancer were obtained from GEO and processed with the TIDE algorithm to predict their responses to ...

Emerging Molecular Biomarkers in Advanced Prostate Cancer

On a lesional level, sensitivity and specificity were 76.6% and 100%, respectively. A patient-based analysis revealed a sensitivity of 88.1%. Especially ...